JP2003510079A - ナトリウムチャンネルβ１Ａサブユニットに関連する方法および組成物 - Google Patents

ナトリウムチャンネルβ１Ａサブユニットに関連する方法および組成物

Info

Publication number
JP2003510079A
JP2003510079A JP2001526953A JP2001526953A JP2003510079A JP 2003510079 A JP2003510079 A JP 2003510079A JP 2001526953 A JP2001526953 A JP 2001526953A JP 2001526953 A JP2001526953 A JP 2001526953A JP 2003510079 A JP2003510079 A JP 2003510079A
Authority
JP
Japan
Prior art keywords
subunit
sodium channel
cells
nucleic acid
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001526953A
Other languages
English (en)
Japanese (ja)
Inventor
エル イソム，ロリ
カゼン−ジレスピー，クリスチン
イー ロジャース，カスリン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan
Original Assignee
University of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan filed Critical University of Michigan
Publication of JP2003510079A publication Critical patent/JP2003510079A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
JP2001526953A 1999-09-30 2000-09-29 ナトリウムチャンネルβ１Ａサブユニットに関連する方法および組成物 Pending JP2003510079A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15683799P 1999-09-30 1999-09-30
US60/156,837 1999-09-30
PCT/US2000/027119 WO2001023571A1 (fr) 1999-09-30 2000-09-29 PROCEDES ET COMPOSITIONS RELATIFS AUX SOUS-UNITES β1A DE CANAUX SODIQUES

Publications (1)

Publication Number Publication Date
JP2003510079A true JP2003510079A (ja) 2003-03-18

Family

ID=22561303

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001526953A Pending JP2003510079A (ja) 1999-09-30 2000-09-29 ナトリウムチャンネルβ１Ａサブユニットに関連する方法および組成物

Country Status (5)

Country Link
EP (1) EP1216300A1 (fr)
JP (1) JP2003510079A (fr)
AU (2) AU7743500A (fr)
CA (1) CA2381771A1 (fr)
WO (2) WO2001023570A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2411069A1 (fr) 2000-06-07 2001-12-13 Ortho-Mcneil Pharmaceutical, Inc. Sous-unites beta-1a humaines du canal sodium electriquement potentialise et procedes d'utilisation
SI1458386T1 (sl) 2001-12-27 2007-08-31 Ortho Mcneil Pharm Inc Aroil pirol heteroeril in metanoli, uporabni za zdravljenje motnje centralnega živčnega sistema
DE60224002T2 (de) * 2002-02-14 2008-11-06 Biofrontera Pharmaceuticals Ag Kathepsin Y Inhibitoren für die Entwicklung von Medikamenten zur Schmerzbehandlung

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1171589A1 (fr) * 1999-04-15 2002-01-16 Cambridge University Technical Services Limited Nouvelle famille de proteines sous-unite g(b) du canal sodique potentio-dependant, acides nucleiques codant pour elles et leur utilisation a des fins therapeutiques et diagnostiques
AU5010900A (en) * 1999-05-14 2000-12-05 Millennium Pharmaceuticals, Inc. Gene encoding a sodium channel beta-3 subunit protein

Also Published As

Publication number Publication date
AU7743500A (en) 2001-04-30
AU7746100A (en) 2001-04-30
CA2381771A1 (fr) 2001-04-05
EP1216300A1 (fr) 2002-06-26
WO2001023570A2 (fr) 2001-04-05
WO2001023570A3 (fr) 2001-10-25
WO2001023571A1 (fr) 2001-04-05

Similar Documents

Publication Publication Date Title
US20170174763A1 (en) NOGO Receptor-Mediated Blockade of Axonal Growth
US11932908B2 (en) Compositions and methods for diagnosis and treatment of epilepsy
JP3497133B2 (ja) Ａ−３３関連抗原およびそれらの薬理学的使用
JP2002112772A (ja) 新規ポリペプチドおよびそのｄｎａ
EP1351968B1 (fr) Mutations dans la sous-unite alpha1 du canal sodique du gene neuronal, polypeptides associes, et traitement du syndrome gefs+ (epilepsie generalisee avec crises febriles +)
JP2003510079A (ja) ナトリウムチャンネルβ１Ａサブユニットに関連する方法および組成物
US20050032155A1 (en) Mutation in the beta2 nicotinic acetycholine receptor subunit associated with nocturnal frontal lobe epilepsy
US6586581B1 (en) Prolactin regulatory element binding protein and uses thereof
JPWO2001081401A1 (ja) 新規コレクチン
JP2002512041A (ja) 緑内障および前眼部形成不全の診断および予後判定のためのｆｒｅａｃ３遺伝子における新規変異
US20040191791A1 (en) Novel mutation
RU2208230C2 (ru) Icam-4 и его диагностическое использование
AU2002216826B2 (en) Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
JP2004208583A (ja) 新規免疫抑制性受容体
Lines Towards a unified cellular role for the Axenfeld-Rieger malformation genes PITX2 and FOXC1
US20090233986A1 (en) Methods and compositions for using sax2
Misener The Production and Analysis of LSP1-deficient Mice
AU2002252833A1 (en) Novel mutation
JP2004121246A (ja) 神経変性疾患の予防・治療剤
AU2001256003A1 (en) Mutation in the beta2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
WO2002012439A2 (fr) Genes associes a des maladies renales